Neurology News

Lusaris Therapeutics announced its launch with $60 million in Series A financing to advance LSR-1019, a sublingual formulation of 5-MeO-DMT for patients with treatment-resistant depression and other severe neuropsychiatric disorders.

CHICAGO — A literature-based discovery machine learning algorithm suggested that antihistamines could be adjuvants to levodopa for Parkinson’s disease, a poster showed at the 2022 American Neurological Association annual meeting.

CHICAGO — A history of two or more head injuries was associated with mild behavioral impairment in older adults, according to a poster presentation at the 2022 American Neurological Association annual meeting.

CHICAGO — Impairments in decision-making may be among the earliest signs of cognitive decline, according to a presenter at the 2022 American Neurological Association annual meeting.

CHICAGO — COVID-19-induced hyposmia eliminated odor-induced migraine headaches in an older adult, a case study presented at the 2022 American Neurological Association’s annual meeting showed.

CHICAGO — Low-income and underrepresented populations are at greater risk for neurodevelopmental effects related to chemical exposures, according to an expert at the 2022 American Neurological Association annual meeting.

CHICAGO — Divyanshu Dubey, MBBS, discusses the use of antibody evaluations in the workup for neuropathies during a presentation at the 2022 American Neurological Association’s annual meeting.

CHICAGO — Igor J. Koralnik, MD, discusses highlights from his presentation at the 2022 American Neurological Association’s annual meeting on long COVID and its effect on the nervous system.

CHICAGO — Older age at symptom onset and select pathologies were associated with shorter symptom duration in patients with rapidly progressive dementia, according to a poster at ANA 2022.

CHICAGO — Roy H. Hamilton, MD, MS, discusses a symposium at the 2022 American Neurological Association’s annual meeting that focused on Alzheimer’s disease and MS and the disproportionate burden that underrepresented groups experience.